Helicobacter pylori Activates the Cyclin D1 Gene through Mitogen- Activated Protein Kinase Pathway in Gastric Cancer Cells

doi:10.1128/IAI.69.6.3965-3971.2001

Infect Immun. 2001 June; 69(6): 3965–3971.

doi: 10.1128/IAI.69.6.3965-3971.2001

PMCID: PMC98458

Helicobacter pylori Activates the Cyclin D1 Gene through Mitogen- Activated Protein Kinase Pathway in Gastric Cancer Cells

Yoshihiro Hirata,^* Shin Maeda, Yuzo Mitsuno, Masao Akanuma, Yutaka Yamaji, Keiji Ogura, Haruhiko Yoshida, Yasushi Shiratori, and Masao Omata

Department of Gastroenterology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

Editor: J. D. Clements

^*Corresponding author. Mailing address: Department of Gastroenterology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 3-3815-5411, ext. 33056. Fax: 3-3814-0021. E-mail: HIRATAY-INT/at/h.u-tokyo.ac.jp.

Received November 27, 2000; Revisions requested February 2, 2001; Accepted March 26, 2001.

This article has been cited by other articles in PMC.

Abstract

Helicobacter pylori induces cellular proliferation in host cells, but the mechanism remains unclear. Thus, we examined the effect of H. pylori on cyclin D1, an important regulator of the cell cycle, especially in relation to intracellular signaling pathways. In a Northern blot analysis, cyclin D1 transcription in gastric cancer (AGS) cells was enhanced by coculture with H. pylori strain TN2 in a time-dependent and multiplicity-of-infection-dependent manner. An isogenic mutant form of vacA also increased cyclin D1 transcription, but mutant forms of cagE or the entire cag pathogenicity island did not enhance cyclin D1 transcription. These effects were confirmed with a luciferase assay of the cyclin D1 promoter (pD1luc). Cyclin D1 promoter activation by H. pylori was inhibited by MEK inhibitors (U0126 and PD98059), indicating that the mitogen-activated protein kinase pathway may be involved in intracellular signal transduction. In contrast, transfection of a reporter plasmid having any point mutations of the NF-κB binding sites in the promoter (pD1-κB1M, pD1-κB2M, or pD1-κB1/2M) or cotransfection of dominant negative IκBα did not affect cyclin D1 activation by H. pylori. In conclusion, H. pylori activates cyclin D1 through the mitogen-activated protein kinase pathway and not through NF-κB activation in AGS cells. This activation of cyclin D1 is partly dependent on the cag pathogenicity island but not on vacA.

Colonization of the human gastric mucosa by Helicobacter pylori induces various diseases, such as atrophic gastritis, peptic ulcer diseases, and gastric adenocarcinoma (12, 21, 23, 28, 30, 34). It has been recently demonstrated that H. pylori affects intracellular signal conduction in host cells, leading to the activation of transcriptional factors (18, 19, 22, 24, 25, 42) and the induction of proinflammatory cytokines (8, 29, 32, 41). The cag pathogenicity island (PAI) genes of H. pylori and their products are responsible for the bacterium-host interactions, including activation of the NF-κB and mitogen-activated protein (MAP) kinase pathways (19, 22, 24, 25, 42). The cag PAI genes have been suggested as the cause of gastric diseases in vivo (3, 6, 21), and we confirmed this in the Mongolian gerbil model (33).

H. pylori infection is also associated with enhanced cellular proliferation of host cells (9, 14, 16, 36, 37); however, the mechanism of cellular proliferation induced by H. pylori infection remains unclear. In mammalian cells, cellular proliferation is regulated in a cell cycle governed by the sequential formation and degradation of cyclins and cyclin-dependent kinases. Among various cyclins, cyclin D1 regulates passage through the restriction point and entry into the S phase (43). Furthermore, cyclin D1 overexpression shortens the G₁ phase and increases the rate of cellular proliferation (15, 38–40). Various factors, such as the MAP kinase cascade (20), NF-κB (13), and the Wnt signal (44, 47), are known regulators of cyclin D1 expression. In addition, some of these factors are already known to be activated by H. pylori infection; however, little is known about the effect of H. pylori infection on cyclin D1 expression. Thus, in this study, we tried to elucidate the mechanism of host cell proliferation caused by H. pylori in relation to cyclin D1 transcription.

MATERIALS AND METHODS

Cell culture.

Human gastric adenocarcinoma cell line AGS cells were maintained in Ham's F12 medium supplemented with 10% fetal bovine serum (Life Technologies, Inc., Grand Island, N.Y.) in an incubator with 5% CO₂.

Bacterial strains and growth conditions.

H. pylori strain TN2 possessing both the cag PAI and vacA was generously donated by M. Nakao (Takeda Chemical Industries, Ltd., Osaka, Japan). Infection with this strain induced gastric cancer in Mongolian gerbils (49). The isogenic mutants cagE-disrupted TN2-ΔcagE and vacA-disrupted TN2-ΔvacA were prepared as described previously (22, 32). TN2-ΔPAI, a strain in which all of the PAI genes are disrupted, was prepared as follows. A partial fragment of the cagA gene (700 bp) was amplified by PCR and cloned into the plasmid vector pCRII (Invitrogen, San Diego, Calif.). A 700-bp fragment of the cag5 gene, which is localized in cagII, was also amplified and cloned into pCRII containing a cagA gene fragment at the KpnI site oriented in the same direction. A kanamycin resistance gene cassette was then inserted into the vector at the BamHI site between cagA and the cag5 fragment. The resulting construct was transferred into parental H. pylori cells (strain TN2) by electroporation. After selection by kanamycin resistance and Southern blot hybridization to confirm the disruption of the genes, a clone was selected for use as TN2-ΔPAI.

These strains were grown in brucella broth with 5% (vol/vol) fetal bovine serum under microaerobic conditions (Campy-Pak Systems; BBL, Cockeysville, Md.), diluted to the desired multiplicity of infection (MOI), and then used for experiments. The number of bacterial cells in the suspension was quantified by optical density measurements.

Heat-killed H. pylori was prepared by boiling the bacteria for 30 min. H. pylori filtrate was prepared by suspending the bacteria in antibiotic-free medium for 30 min, pelleting the bacteria by centrifugation, and then filtering the medium through a 0.22-μm-pore-size filter (Nihon Millipore Ltd., Tokyo, Japan).

Plasmids.

Cyclin D1 promoter-containing construct pD1luc and vectors pD1-κB1M, pD1-κB2M, and pD1-κB1/2M, possessing mutations in their NF-κB binding sites, were kindly donated by M. Strauss (Humboldt Universität, Berlin, Germany). Plasmid pD1luc is consistent with an EcoRI/PvuII fragment (1,226 bp) of the cyclin D1 promoter. pD1-κB1M possesses mutations in the NF-κB binding site between nucleotides −840 and −831, pD1-κB2M has mutations in the NF-κB binding site between nucleotides −33 and −24, and pD1-κB1/2M possesses both of these mutations (13, 27). The dominant-negative IκBα expression vector mutant (SS32/36AA) was generously donated by H. Suzuki (Yamanouchi Pharmaceutical Co., Ltd., Ibaraki, Japan) (46).

Northern blot analysis.

AGS cells were serum starved for 72 h and subsequently cultured with H. pylori at an MOI of 10 to 300. Cells were harvested at the times indicated, and total RNA was isolated by using Isogen (Wako, Osaka, Japan) in accordance with the manufacturer's instructions. Fifteen micrograms of total RNA was loaded onto a 1% agarose–formaldehyde gel, separated by electrophoresis, and then transferred onto a Hybond N membrane (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom).

Partial cDNA (200 bp) for cyclin D1 was produced by PCR using primers 5′-ATGGAACACCAGCTCCTGTG-3′ (forward) and 5′-ACCTCCAGCATCCAGGTGGC-3′ (reverse). The DNA sequence of the product was confirmed by using a cycle DNA sequencing system (Perkin-Elmer Applied Biosystems, Foster City, Calif.). This cyclin D1 probe was labeled with an AlkPhos Direct Labelling Module (Amersham Pharmacia Biotech) used in accordance with the manufacturer's instructions and then hybridized with the membrane for 12 h. After several washes of the membrane, cyclin D1 mRNA was detected by CDP-Star Detection Reagent (Amersham Pharmacia Biotech), followed by analysis using the LAS1000 imaging system (Fuji Photo Film Co., Ltd., Tokyo, Japan).

After the hybridization, the membrane was reprobed with the human gene for glyceraldehyde 3-phosphate dehydrogenase to control for equal loading of the RNA.

Transfections and luciferase assays.

AGS cells (1.5 × 10⁵) were seeded into six-well plates and transfected 24 h later with 200 ng of pD1luc or the mutant vector and the indicated expression vectors using FuGENE 6 Transfection Reagent (Roche Diagnostic Corporation, Indianapolis, Ind.). Ten nanograms of Renilla luciferase vector (Promega, Madison, Wis.) was included in each sample for standardization of transfection efficiency. The total DNA amount was kept constant by supplementation with empty vectors. After 24 h, H. pylori (strain TN2 or an isogenic mutant) was added at an MOI of 10 to 100 and incubated for the indicated times. 12-O-Tetradecanoylphorbol-13-acetate (TPA) (5 to 50 ng/ml) was used as a positive control. When evaluating the effect of the MAP kinase signaling pathway on activation of the cyclin D1 promoter, the specific MEK inhibitor PD98059 (Wako) or U0126 (Promega) (10) or vehicle (dimethyl sulfoxide) alone was added 2 h before coculture with H. pylori. The cells were harvested and washed with phosphate-buffered saline and lysed in a luciferase lysis buffer (Piccagene; Toyo Ink, Tokyo, Japan). The lysates were assayed for luciferase and seapansy luciferase activity with a luminometer. After standardization with seapansy luciferase activity, luciferase activity was calculated and represented as the fold induction, compared with the control, of more than three independent experiments.

Statistical analysis.

The significance of differences was assessed by analysis of variance and, if the F value was significant, by Dunnett's post hoc tests.

RESULTS

H. pylori increases transcription of the cyclin D1 gene in gastric cancer cells in a time- and MOI-dependent manner.

When serum-starved AGS cells were cocultured with H. pylori strain TN2 at an MOI of 100, the amount of cyclin D1 mRNA was markedly increased from 60 to 120 min, as observed by Northern blot analysis (Fig. (Fig.1A).1A). A similar increase in the cyclin D1 gene was observed when AGS cells were incubated with H. pylori at different MOIs. H. pylori increased transcription of the cyclin D1 gene in an MOI-dependent manner up to an MOI of 100 (Fig. (Fig.1B).1B).

FIG. 1

H. pylori induces cyclin D1 mRNA and activates the cyclin D1 promoter in AGS cells. (A) AGS cells were serum starved for 72 h and infected with H. pylori strain TN2 at an MOI of 100 for the times indicated, and cyclin D1 mRNA was measured by Northern (more ...)

In the reporter assay using pD1luc, cyclin D1 promoter activity was enhanced in cells cocultured with H. pylori (Fig. (Fig.1C)1C) in a time-dependent manner, in the same way as in cells treated with TPA at 50 ng/ml (Fig. (Fig.1D).1D). Cyclin D1 promoter activity was increased 1.4-fold by 8 h, 3.0-fold by 16 h, and 6.4-fold by 24 h of incubation with H. pylori, compared with that of an uninfected control. MOI-dependent transactivation was also observed in cells cocultured with H. pylori for 24 h (Fig. (Fig.1E),1E), as was observed in cells treated with TPA (Fig. (Fig.1F).1F). This activation was observed only when live bacteria were added to the cells. Neither heat-killed bacteria nor bacterial filtrate activated the cyclin D1 promoter (Fig. (Fig.1G).1G). Subsequent reporter assays were performed with cells cocultured with live H. pylori at an MOI of 100 for 24 h.

Effects of virulence factors on cyclin D1 transcription in AGS cells.

To assess the relationship between the virulence genes of H. pylori and cyclin D1 activation, AGS cells were cultured with isogenic mutant strain TN2-ΔcagE, TN2-ΔvacA, or TN2-ΔPAI at an MOI of 100. Northern blot analysis showed that the induction of cyclin D1 mRNA by TN2-ΔcagE and TN2-ΔPAI was significantly less than that by wild-type TN2; however, disruption of the vacA gene did not affect cyclin D1 induction (Fig. (Fig.2A).2A).

FIG. 2

Effects of virulence factors of H. pylori on cyclin D1 transcription. (A) AGS cells were infected with several isogenic mutant strains of H. pylori (TN2, TN2-ΔcagE, TN2-ΔPAI, and TN2-ΔvacA) at an MOI of 100 for 90 min. Cyclin D1 (more ...)

A luciferase reporter assay showed that TN2-ΔcagE and TN2-ΔPAI induced 4.5- and 3.7-fold increases in cyclin D1 promoter activity, respectively. The induction by TN2-ΔPAI was significantly less than that by wild-type TN2 (P < 0.05). In contrast, TN2-ΔvacA induced a 6.7-fold increase in cyclin D1 promoter activity, a value similar to that of wild-type TN2 (Fig. (Fig.22B).

MAP kinase activation is required for induction of cyclin D1 by H. pylori.

Since cyclin D1 expression is regulated by MAP kinase cascades, we examined whether the MAP kinase cascade is involved in H. pylori-induced cyclin D1 transcription by using the specific MEK inhibitors U0126 and PD98059. U0126 (5 to 20 μM) and PD98059 (50 to 200 μM) were added to the culture medium of AGS cells 2 h before coculture with H. pylori. Activation of the cyclin D1 promoter by H. pylori was markedly inhibited by each compound in a dose-dependent manner (Fig. (Fig.3A3A and B), as was observed in the cells treated with TPA (data not shown). U0126, at a dose of 20 μM, reduced cyclin D1 promoter activation to 34% (P < 0.05), and PD98059, at a dose of 200 μM, reduced promoter activation to 21% (P < 0.05). With the Northern blot analysis, preincubation of the cells with U0126 or PD98059 reduced cyclin D1 mRNA induction by coculture with H. pylori (Fig. (Fig.3C).3C).

FIG. 3

Role of MAP kinase activation in the induction of cyclin D1 promoter by H. pylori. AGS cells transfected with pD1luc were infected with H. pylori at an MOI of 100 or left uninfected in the presence of the MEK inhibitor U0126 (A) or PD98059 (B) or dimethyl (more ...)

Effect of NF-κB activation on H. pylori-induced cyclin D1 promoter transactivation.

We examined the role of NF-κB activation on H. pylori-induced cyclin D1 transcription since the type 1 strain of H. pylori can activate NF-κB and cyclin D1 transcription is also reportedly regulated by NF-κB. We examined the effect of H. pylori on the promoter constructs containing point mutations in the κB sites (pD1-κB1M, pD1-κB2M, and pD1-κB1/2M). These mutant reporters were transfected into AGS cells instead of pD1luc, and luciferase expression induced by H. pylori was measured. Coculture with H. pylori caused about a sixfold increase in the activation of luciferase expression on each promoter construct (Fig. (Fig.4A).4A).

FIG. 4

Role of NF-κB activation on H. pylori-induced cyclin D1 promoter transactivation. (A) AGS cells transiently transfected with 200 ng of pD1luc or a mutant reporter (pD1-κB1M, pD1-κB2M, or pD1-κB1/2M) were infected with (more ...)

In addition, we cotransfected the dominant negative form of IκBα (SS32/36AA) with pD1luc to inhibit NF-κB activation by H. pylori. Although activation of NF-κB was completely inhibited by this dominant-negative form of IκBα (22), induction of the cyclin D1 promoter was not reduced by the mutant of IκBα (Fig. (Fig.4B).4B). These data indicate that H. pylori transactivates the cyclin D1 promoter independently of NF-κB activation in AGS cells.

DISCUSSION

In this study, we demonstrated that live H. pylori transactivates cyclin D1, one of the critical regulators of the cell cycle, in AGS cells in a time- and dose-dependent manner. Although many studies have revealed that H. pylori induces cellular proliferation (9, 14, 16, 36, 37), the underlying mechanism has not yet been clarified. Our result indicating that H. pylori directly affects the cell cycle regulator molecule represents one possible reason for cellular proliferation. Furthermore, overexpression of cyclin D1 has been demonstrated to contribute to the oncogenic transformation of cells in vitro and in vivo (1, 4, 11, 26, 48, 50). Although little is known about the relationship between cyclin D1 and gastric cancer, transactivation of cyclin D1 and an accelerated cell cycle caused by H. pylori infection can be among the factors contributing to malignant transformation.

We also demonstrated the effects of virulence genes of H. pylori on cyclin D1 activation. In a Northern blot analysis, TN2-ΔcagE and TN2-ΔPAI exerted weaker effects on H. pylori-induced cyclin D1 activation compared with wild-type TN2, while TN2-ΔvacA induced cyclin D1 transcription at a level similar to that of the wild type. In the reporter assay, strains containing all of the cag PAI genes (TN2 and TN2-ΔvacA) activated the promoter more strongly than did strains partially or completely lacking cag PAI genes (TN2-ΔcagE and TN2-ΔPAI). Although we did not evaluate the cell cycle directly, these data may be compatible with a previous report by Peek et al. which demonstrated that H. pylori possessing cag PAI accelerated the progression of the cell cycle from G₁ into G₂-M in AGS cells at 6 h (37). We have recently demonstrated in the Mongolian gerbil model that TN2-ΔcagE did not induce any severe gastric diseases, in contrast to wild-type TN2 and TN2-ΔvacA, in spite of the similar colonization abilities (33). Together with other host responses such as transcriptional factor activation (18, 19, 22, 24, 25, 42) and apoptosis (17, 37), which can be enhanced by cag PAI-positive H. pylori, accelerated cell proliferation may provide one of the reasons for the high prevalence of gastric cancer in patients suffering from cag PAI-positive H. pylori (3, 21, 35).

It is not known, however, how cag PAI genes contribute to the differences in host response. Possibly only cag PAI-positive strains transport certain molecules of H. pylori, which directly activate intracellular signal transduction. Some of the cag PAI genes and their products have been thought to form a type IV secretion system (5, 7). Very recently, CagA protein was reported to be transported into AGS cells by this secretion system and the transportation was blocked by cagE knockout (2, 31, 45). However, since the mutant strains used in this study also weakly induced cyclin D1 transcription, the proteins transported by this secretion system cannot be the sole molecules responsible for cyclin D1 activation.

In the Northern blot analysis, an increased level of cyclin D1 mRNA was observed 60 to 120 min after coculture with H. pylori. The time-dependent increase in cyclin D1 mRNA levels was also observed when MKN-28 cells were cocultured with H. pylori (data not shown). This time lag suggests an involvement of intracellular signal transduction. Cyclin D1 expression is regulated by many signaling cascades, such as mitogenic stimuli and the MAP kinase cascade, inflammation and NF-κB activation, and Wnt signaling (13, 20, 44, 47). Some of these signaling cascades are involved in H. pylori-mediated host responses. Thus, we determined the intracellular signaling pathway for H. pylori-induced cyclin D1 activation.

The present results showing that MEK inhibitors reduced H. pylori-induced cyclin D1 activation suggest the involvement of MAP kinase cascades. Since the cag PAI mutant strains are known to be less potent in activating the MAP kinase cascades (19, 24, 25), less activation of cyclin D1, as shown by the mutant strains used in this study, is reasonable. We also performed in vitro kinase assays to measure MAP kinase activity, and we confirmed that H. pylori had the ability to activate MAP kinase, and this ability was correlated with the status of cag PAI (data not shown). On the other hand, the use of a mutant reporter plasmid of the NF-κB binding site or dominant-negative IκBα expression vector in the present study showed that NF-κB activation is not required for cyclin D1 transactivation in AGS cells.

In conclusion, we have demonstrated that H. pylori activates cyclin D1 expression and that this activation is partly dependent on the cag PAI genes. Furthermore, cyclin D1 expression was activated through the MAP kinase signaling pathway but not by activation of NF-κB. It is possible that other signaling pathways which can be induced by H. pylori exist, as well as another mechanism for cyclin D1 transactivation. These possibilities should be investigated in future studies.

ACKNOWLEDGMENTS

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture (11557040).

We appreciate the generous donation of plasmid constructs by M. Strauss and H. Suzuki, and we thank Mitsuko Tsubouchi for excellent technical assistance.

REFERENCES

1. Arber N, Hibshoosh H, Moss S F, Sutter T, Zhang Y, Begg M, Wang S, Weinstein I B, Holt P R. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 1996;110:669–674. [PubMed]

2. Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, Suzuki T, Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med. 2000;191:593–602. [PMC free article] [PubMed]

3. Blaser M J, Perez-Perez G I, Kleanthous H, Cover T L, Peek R M, Chyou P H, Stemmermann G N, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995;55:2111–2115. [PubMed]

4. Buckley M F, Sweeney K J, Hamilton J A, Sini R L, Manning D L, Nicholson R I, deFazio A, Watts C K, Musgrove E A, Sutherland R L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 1993;8:2127–2133. [PubMed]

5. Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 1996;93:14648–14653. [PubMed]

6. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N, Rappuoli R. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA. 1993;90:5791–5795. [PubMed]

7. Covacci A, Telford J L, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328–1333. [PubMed]

8. Crabtree J E, Wyatt J I, Trejdosiewicz L K, Peichl P, Nichols P H, Ramsay N, Primrose J N, Lindley I J. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994;47:61–66. [PMC free article] [PubMed]

9. Fan X G, Kelleher D, Fan X J, Xia H X, Keeling P W. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut. 1996;38:19–22. [PMC free article] [PubMed]

10. Favata M F, Horiuchi K Y, Manos E J, Daulerio A J, Stradley D A, Feeser W S, Van Dyk D E, Pitts W J, Earl R A, Hobbs F, Copeland R A, Magolda R L, Scherle P A, Trzaskos J M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998;273:18623–18632. [PubMed]

11. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger H G. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res. 1997;57:1634–1637. [PubMed]

12. Graham D Y, Lew G M, Klein P D, Evans D G, Evans D J, Jr, Saeed Z A, Malaty H M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992;116:705–708. [PubMed]

13. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-κB function in growth control: regulation of cyclin D1 expression and G₀/G₁-to-S-phase transition. Mol Cell Biol. 1999;19:2690–2698. [PMC free article] [PubMed]

14. Jang T J, Kim J R. Proliferation and apoptosis in gastric antral epithelial cells of patients infected with Helicobacter pylori. J Gastroenterol. 2000;35:265–271. [PubMed]

15. Jiang W, Kahn S M, Zhou P, Zhang Y J, Cacace A M, Infante A S, Doi S, Santella R M, Weinstein I B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene. 1993;8:3447–3457. [PubMed]

16. Jones N L, Shannon P T, Cutz E, Yeger H, Sherman P M. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol. 1997;151:1695–1703. [PubMed]

17. Jones N L, Day A S, Jennings H A, Sherman P M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun. 1999;67:4237–4242. [PMC free article] [PubMed]

18. Keates S, Hitti Y S, Upton M, Kelly C P. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology. 1997;113:1099–1109. [PubMed]

19. Keates S, Keates A C, Warny M, Peek R M, Murray P G, Kelly C P. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag⁺ and cag⁻Helicobacter pylori. J Immunol. 1999;163:5552–5559. [PubMed]

20. Lavoie J N, L'Allemain G, Brunet G, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem. 1996;271:20608–20616. [PubMed]

21. Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune K, Kawabe T, Shiratori Y, Omata M. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer. 2000;88:1530–1535. [PubMed]

22. Maeda S, Yoshida H, Ogura K, Mitsuno Y, Hirata Y, Yamaji Y, Akanuma M, Shiratori Y, Omata M. Helicobacter pylori activates NF-κB through a signaling pathway involving I-κB kinases, NF-κB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology. 2000;119:97–108. [PubMed]

23. Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;i:1311–1315. [PubMed]

24. Meyer-Ter-Vehn T, Covacci A, Kist M, Pahl H L. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem. 2000;275:16064–16072. [PubMed]

25. Mitsuno, Y., H. Yoshida, S. Maeda, K. Ogura, Y. Hirata, T. Kawabe, Y. Shiratori, and M Omata.Helicobacter pylori-induced transactivation of SRE and AP-1 through the ERK signaling pathway in gastric cancer cells. Gut, in press. [PMC free article] [PubMed]

26. Motokura T, Bloom T, Kim H G, Juppner H, Ruderman J V, Kronenberg H M, Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350:512–515. [PubMed]

27. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA. 1994;91:2945–2949. [PubMed]

28. NIH Consensus Development Panel. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc. 1994;272:65–69. [PubMed]

29. Noach L A, Bosma N B, Jansen J, Hoek F J, van Deventer S J, Tytgat G N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994;29:425–429. [PubMed]

30. Nomura A, Stemmermann G N, Chyou P H, Kato I, Perez-Perez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132–1136. [PubMed]

31. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287:1497–1500. [PubMed]

32. Ogura K, Takahashi M, Maeda S, Ikenoue T, Kanai F, Yoshida H, Shiratori Y, Mori K, Mafune K, Omata M. Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori. Dig Dis Sci. 1998;43:2738–2743. [PubMed]

33. Ogura K, Maeda S, Nakao M, Watanabe T, Tada M, Kyutoku T, Yoshida H, Shiratori Y, Omata M. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med. 2000;192:1601–1610. [PMC free article] [PubMed]

34. Parsonnet J, Friedman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N, Sibley R K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–1131. [PubMed]

35. Parsonnet J, Friedman G D, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997;40:297–301. [PMC free article] [PubMed]

36. Peek R M, Jr, Moss S F, Tham T K T, Perez-Perez G I, Wang S, Miller G G, Atherton J C, Holt P R, Blaser M J. Helicobacter pylori cagA⁺ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst. 1997;89:863–868. [PubMed]

37. Peek R M, Jr, Blaser M J, Mays D J, Forsyth M H, Cover T L, Song S Y, Krishna U, Pietenpol J A. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res. 1999;59:6124–6131. [PubMed]

38. Quelle D E, Ashmun R A, Shurtleff S A, Kato J Y, Bar-Sagi D, Roussel M F, Sherr C J. Overexpression of mouse D-type cyclins accelerates G₁ phase in rodent fibroblasts. Genes Dev. 1993;7:1559–1571. [PubMed]

39. Resnitzky D, Reed S I. Different roles for cyclins D1 and E in regulation of the G₁-to-S transition. Mol Cell Biol. 1995;15:3463–3469. [PMC free article] [PubMed]

40. Robles A I, Larcher F, Whalin R B, Murillas R, Richie E, Gimenez-Conti I B, Jorcano J L, Conti C J. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci USA. 1996;93:7634–7638. [PubMed]

41. Sharma S A, Tummuru M K, Miller G G, Blaser M J. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995;63:1681–1687. [PMC free article] [PubMed]

42. Sharma S A, Tummuru M K, Blaser M J, Kerr L D. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol. 1998;160:2401–2407. [PubMed]

43. Sherr C J. Cancer cell cycles. Science. 1996;274:1672–1677. [PubMed]

44. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522–5527. [PubMed]

45. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA. 2000;97:1263–1268. [PubMed]

46. Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Suzuki T, Ichiyama A, Ikenoue T, Omata M, Furuichi K, Tanaka K. IκBα ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, βTrCP1 and βTrCP2. Biochem Biophys Res Commun. 1999;256:127–132. [PubMed]

47. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–426. [PubMed]

48. Wang T C, Cardiff R D, Zukerberg L, Lees E, Arnold A, Schmidt E V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994;369:669–671. [PubMed]

49. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 1998;115:642–648. [PubMed]

50. Weinstat-Saslow D, Merino M J, Manrow R E, Lawrence J A, Bluth R F, Wittenbel K D, Simpson J F, Page D L, Steeg P S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med. 1995;1:1257–1260. [PubMed]

Articles from Infection and Immunity are provided here courtesy of
American Society for Microbiology (ASM)